花园生物
(300401)
| 流通市值：79.67亿 | | | 总市值：80.98亿 |
| 流通股本：5.35亿 | | | 总股本：5.43亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 326,391,133.03 | 1,243,283,228.76 | 937,594,175.86 | 600,172,551.54 |
| 营业收入 | 326,391,133.03 | 1,243,283,228.76 | 937,594,175.86 | 600,172,551.54 |
| 二、营业总成本 | 225,274,384.48 | 952,332,834.6 | 715,840,066.86 | 478,577,762.2 |
| 营业成本 | 140,990,085.57 | 516,751,694.83 | 392,198,511.26 | 256,043,644.53 |
| 税金及附加 | 4,542,782.79 | 23,072,483 | 14,171,596.61 | 10,742,863.52 |
| 销售费用 | 36,903,134.01 | 193,576,190.68 | 155,333,590.49 | 107,473,005.41 |
| 管理费用 | 22,790,616.72 | 115,796,934.93 | 75,536,883.45 | 53,181,235.55 |
| 研发费用 | 16,376,140.28 | 83,778,120.03 | 59,691,953 | 41,046,604.07 |
| 财务费用 | 3,671,625.11 | 19,357,411.13 | 18,907,532.05 | 10,090,409.12 |
| 其中:利息费用 | 7,909,114.98 | 35,634,971.23 | 28,140,264.6 | 19,326,387 |
| 其中:利息收入 | 1,867,757.07 | 10,291,003.7 | 8,105,533.59 | 5,926,480.86 |
| 加:公允价值变动收益 | 1,000,109.59 | 245,210.96 | - | - |
| 加:投资收益 | - | 716,902.82 | 535,219.09 | 313,047.8 |
| 资产处置收益 | 183.12 | 31,530,438.85 | 31,623,354.74 | 31,736,406.76 |
| 资产减值损失(新) | - | -2,505,142.09 | 491,098.25 | 491,098.25 |
| 信用减值损失(新) | -983,515.72 | -1,974,128.16 | -3,042,912.76 | -873,891 |
| 其他收益 | 5,224,300.96 | 36,435,671.31 | 20,736,766.04 | 9,156,476.89 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 106,357,826.5 | 355,399,347.85 | 272,097,634.36 | 162,417,928.04 |
| 加:营业外收入 | 5,467,820.28 | 4,232,319.77 | 1,731,336.91 | 639,787.14 |
| 减:营业外支出 | 75,964.43 | 938,247.5 | 570,622.87 | 521,708.38 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 111,749,682.35 | 358,693,420.12 | 273,258,348.4 | 162,536,006.8 |
| 减:所得税费用 | 15,239,841.24 | 49,484,432.1 | 31,790,531.76 | 20,422,168.02 |
| 六、净利润 | 96,509,841.11 | 309,208,988.02 | 241,467,816.64 | 142,113,838.78 |
| 持续经营净利润 | 96,509,841.11 | 309,208,988.02 | 241,467,816.64 | 142,113,838.78 |
| 归属于母公司股东的净利润 | 96,511,379.04 | 309,212,798.15 | 241,469,851.67 | 142,114,009.14 |
| 少数股东损益 | -1,537.93 | -3,810.13 | -2,035.03 | -170.36 |
| (一)基本每股收益 | 0.18 | 0.57 | 0.45 | 0.26 |
| (二)稀释每股收益 | 0.18 | 0.52 | 0.4 | 0.23 |
| 九、综合收益总额 | 96,509,841.11 | 309,208,988.02 | 241,467,816.64 | 142,113,838.78 |
| 归属于母公司股东的综合收益总额 | 96,511,379.04 | 309,212,798.15 | 241,469,851.67 | 142,114,009.14 |
| 归属于少数股东的综合收益总额 | -1,537.93 | -3,810.13 | -2,035.03 | -170.36 |
| 公告日期 | 2025-04-18 | 2025-03-25 | 2024-10-18 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |